Surgery for papillary thyroid carcinoma: Is lobectomy enough?

Archives of Otolaryngology - Head and Neck Surgery

Volumn 136, Issue 11, 2010, Pages 1055-1061

  Mendelsohn, Abie H ^a   Elashoff, David A ^a   Abemayor, Elliot ^a   St John, Maie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; DISEASE SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LOBECTOMY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT INDICATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; UNITED STATES;

EID: 78449234945     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2010.181     Document Type: Article

References (23)

1. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167- 1214.
2. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246(3):375-384.
3. Percy C, Stanek E III, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981;71(3):242-250.
4. Podnos YD, Smith DD, Wagman LD, Ellenhorn JD. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope. J Surg Oncol. 2007;96(1):3-7.
5. Lin HW, Bhattacharyya N. Survival impact of treatment options for papillary microcarcinoma of the thyroid. Laryngoscope. 2009;119(10):1983-1987.
6. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009;115(16):3801-3807.
7. National Cancer Institute. Overview of the Surveillance Epidemiology and End Results Program. http://seer.cancer.gov/about. Accessed April 20, 2009.
8. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10) . Geneva, Switzerland: World Health Organization; 1992.
9. Shaha AR. TNM classification of thyroid carcinoma. World J Surg. 2007;31(5):879-887.
10. Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol. 1997;4(4):328-333.
11. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998;83(12):2638-2648.
12. Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16(12):1229-1242.
13. Kawahara M, Kono T. Longevity in mice without a father. Hum Reprod. 2010;25(2):457-461.
14. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid cancers. Cancer. 1985;55(9)(suppl):2062-2071.
15. Chow S-M, Law SCK, Mendenhall WM, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(3):784-795.
16. Kim T-H, Yang D-S, Jung K-Y, Kim C-Y, Choi M-S. Value of external irradiation for locally advanced papillary thyroid cancer. Int J Radiat Oncol Biol Phys. 2003;55(4):1006-1012.
17. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998;82(2):375-388.
18. Esik O, Németh G, Eller J. Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observation period. Oncology. 1994;51(4):372-379.
19. Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer: impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer. 1996;77(1):172-180.
20. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75(3):714-720.
21. Yu JB, Gross CP, Wilson LD, Smith BD. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park). 2009;23(3):288-295.
22. Bilimoria KY, Zanocco K, Sturgeon C. Impact of surgical treatment on outcomes for papillary thyroid cancer. Adv Surg. 2008;42:1-12.
23. Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid. 2001;11(9):877-881.